Astrana Health (ASTH) Insider Trades, Congress & Funds

Smart money at a glance

Filings to Nov 10, 2026

No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.

Company insidersForm 4, 90 days: $0
CongressSTOCK Act, 180 days: None
Big funds13F, quarter ended Jun 30, 2026: 1 added, 0 cut
Federal contractsUSAspending.gov, 12 months: No awards

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

Unlock the full results

Questions about ASTH filings

Are insiders buying or selling Astrana Health Inc (ASTH) stock?

Neither. Astrana Health Inc (ASTH) insiders filed no open-market purchases or sales in the 90 days to Nov 10, 2026, according to SEC Form 4 filings.

Which members of Congress have traded ASTH recently?

None. No member of Congress disclosed a ASTH trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this ASTH smart-money data?

This summary uses filings available on Nov 10, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.

13F: filed up to 45 days late.

Smart money on ASTH

Neutral2 sources:
- Politicians
- Funds

Top traders
No tracked positions at the last update
Insiders
No recent insider filings found
Politicians
- Donald Trump, President, sold $1M–$5M, disclosed May 14
- Donald Trump, President, bought $15K–$50K, disclosed May 14
Neutral · thin1 buy · 1 saleExecutive
Executive branch filings. Amounts are filing ranges, not prices, and filings can lag the trade.
Funds
- FMR LLC, trimmed -$16.3M, holdings at Mar 31
- FMR LLC, added +$21.6M, holdings at Jun 30
Neutral · thin1 added · 1 trimmed
Quarter-end 13F holdings changes, not live trades. A trim is not a short.
Fin-fluencers
No recent posts found

Each bar is 100% of that source’s money. The notch marks an even split.

Lean is the direction of the latest moves. Descriptive, not advice.

Questions about ASTH filings

Are insiders buying or selling Astrana Health Inc (ASTH) stock?

Neither. Astrana Health Inc (ASTH) insiders filed no open-market purchases or sales in the 90 days to Nov 10, 2026, according to SEC Form 4 filings.

Which members of Congress have traded ASTH recently?

None. No member of Congress disclosed a ASTH trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this ASTH smart-money data?

Funds

What funds are doing

2 moves · 6 mo

Buys/Adds$21.6MSells/Trims$16.3M

Buys/Adds (1)

FM
FMR LLC
Q2 2026 13F
$21.6M
added
Signals like this: n=13773, 53% finished lower at D15, median -0.4% vs SPY -0.4%

Sells/Trims (1)

FM
FMR LLC
Q1 2026 13F
$16.3M
trimmed
Signals like this: n=7469, 53% finished lower at D15, median -0.5% vs SPY -0.4%

Unlock everything for $29/month

Unlock for $29/month

Reported Nov 5, 2026

Earnings came in 19.0% below what analysts expected.

Documents

Quarterly report10-Q Annual report10-K Every filing

Last report

Nov 5, 2026

Period ending

Sep 30, 2026

Earnings per share

$0.71-19.01% miss

$0.88 expected

Revenue

$1.02B

SEC filing

EPS: Yahoo Finance

Next report

What the street expects next

Previous reports

Quarter / reported	Earnings per share	Beat or miss	Revenue / income	Revenue vs last year
Sep 30, 2026Reported Nov 5, 2026	$0.71est. $0.88	-19.01%miss	$1.02BSEC filing	+7.1%from $956.0M
Jun 30, 2026Reported Aug 6, 2026	$0.80est. $0.73	+9.59%beat	$972.5MSEC filing	+48.5%from $654.8M
Mar 31, 2026Reported May 7, 2026	$0.74est. $0.65	+13.85%beat	$965.1MSEC filing	+55.6%from $620.4M
Dec 31, 2025Reported Mar 2, 2026	$0.42est. $0.33	+28.58%beat	$950.5MYahoo Finance	No year-ago quarter
Sep 30, 2025Reported Nov 6, 2025	$0.67est. $0.61	+9.84%beat	$956.0MSEC filing	+99.7%from $478.7M
Jun 30, 2025Reported Aug 7, 2025	$0.19est. $0.36	-47.22%miss	$654.8MSEC filing	+34.7%from $486.3M
Mar 31, 2025Reported May 8, 2025	$0.44est. $0.33	+33.33%beat	$620.4MSEC filing	+53.4%from $404.4M
Dec 31, 2024Reported Feb 27, 2025	$0.37est. $0.21	+71.82%beat	$2.03B · FYSEC filing	No year-ago quarter

Earnings per share comes from Yahoo Finance where available, then Alpha Vantage or the company release. Revenue comes from company releases, SEC filings, Alpha Vantage or Yahoo Finance. A beat or miss needs an analyst estimate on the same basis as the reported figure, so quarters without one show none. Non-USD amounts carry their currency code.

Open: $34.05
High: $34.50
Low: $32.75
Prev close: $34.50
52-wk high: $51.60
52-wk low: $18.08
Mkt cap: $1.70B
P/E: 31.9x
ROE: +9.8%
Fwd P/E: 9.0x
Beta: 1.24
P/S: 0.4x
P/B: 2.0x
Profit margin: +1.4%
Op margin: +3.9%

Fundamentals

Is the business strong?

Reasonably priced and running thin margins.

Net margin: 1.4%
P/E: 31.94
Forward P/E: 9.01
Market cap: $1.7B

Valuation

P/S0.43
P/B2.00

Quality

Operating margin3.9%
ROE9.8%
ROA2.8%

Growth

Beta1.24

Technicals

Price structure

This stock is under pressure.

Trend

Under pressure

0 / 100

RSI 14

31balanced

20D volatility

59%annualized

52-week range

$33.77

$18.08$51.60

20D support

$31.46recent floor

20D resistance

$41.00recent ceiling

Returns

5D -8.4%20D -12.1%60D -17.3%

Price vs moving averages

SMA20 -9.1%SMA50 -8.5%SMA200 -1.1%

Volume pace

0.79xvs prior 20D

Smart money at a glance

Filings to Nov 10, 2026

No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.

Company insidersForm 4, 90 days: $0
CongressSTOCK Act, 180 days: None
Big funds13F, quarter ended Jun 30, 2026: 1 added, 0 cut
Federal contractsUSAspending.gov, 12 months: No awards

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

Unlock the full results

Questions about ASTH filings

Are insiders buying or selling Astrana Health Inc (ASTH) stock?

Neither. Astrana Health Inc (ASTH) insiders filed no open-market purchases or sales in the 90 days to Nov 10, 2026, according to SEC Form 4 filings.

Which members of Congress have traded ASTH recently?

None. No member of Congress disclosed a ASTH trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this ASTH smart-money data?

13F: filed up to 45 days late.

Smart money on ASTH

Neutral2 sources:
- Politicians
- Funds

Top traders
No tracked positions at the last update
Insiders
No recent insider filings found
Politicians
- Donald Trump, President, sold $1M–$5M, disclosed May 14
- Donald Trump, President, bought $15K–$50K, disclosed May 14
Neutral · thin1 buy · 1 saleExecutive
Executive branch filings. Amounts are filing ranges, not prices, and filings can lag the trade.
Funds
- FMR LLC, trimmed -$16.3M, holdings at Mar 31
- FMR LLC, added +$21.6M, holdings at Jun 30
Neutral · thin1 added · 1 trimmed
Quarter-end 13F holdings changes, not live trades. A trim is not a short.
Fin-fluencers
No recent posts found

Each bar is 100% of that source’s money. The notch marks an even split.

Lean is the direction of the latest moves. Descriptive, not advice.

Questions about ASTH filings

Are insiders buying or selling Astrana Health Inc (ASTH) stock?

Neither. Astrana Health Inc (ASTH) insiders filed no open-market purchases or sales in the 90 days to Nov 10, 2026, according to SEC Form 4 filings.

Which members of Congress have traded ASTH recently?

None. No member of Congress disclosed a ASTH trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this ASTH smart-money data?

Funds

What funds are doing

2 moves · 6 mo

Buys/Adds$21.6MSells/Trims$16.3M

Buys/Adds (1)

FM
FMR LLC
Q2 2026 13F
$21.6M
added
Signals like this: n=13773, 53% finished lower at D15, median -0.4% vs SPY -0.4%

Sells/Trims (1)

FM
FMR LLC
Q1 2026 13F
$16.3M
trimmed
Signals like this: n=7469, 53% finished lower at D15, median -0.5% vs SPY -0.4%

Unlock everything for $29/month

Unlock for $29/month

Reported Nov 5, 2026

Earnings came in 19.0% below what analysts expected.

Documents

Quarterly report10-Q Annual report10-K Every filing

Last report

Nov 5, 2026

Period ending

Sep 30, 2026

Earnings per share

$0.71-19.01% miss

$0.88 expected

Revenue

$1.02B

SEC filing

EPS: Yahoo Finance

Next report

What the street expects next

Previous reports

Quarter / reported	Earnings per share	Beat or miss	Revenue / income	Revenue vs last year
Sep 30, 2026Reported Nov 5, 2026	$0.71est. $0.88	-19.01%miss	$1.02BSEC filing	+7.1%from $956.0M
Jun 30, 2026Reported Aug 6, 2026	$0.80est. $0.73	+9.59%beat	$972.5MSEC filing	+48.5%from $654.8M
Mar 31, 2026Reported May 7, 2026	$0.74est. $0.65	+13.85%beat	$965.1MSEC filing	+55.6%from $620.4M
Dec 31, 2025Reported Mar 2, 2026	$0.42est. $0.33	+28.58%beat	$950.5MYahoo Finance	No year-ago quarter
Sep 30, 2025Reported Nov 6, 2025	$0.67est. $0.61	+9.84%beat	$956.0MSEC filing	+99.7%from $478.7M
Jun 30, 2025Reported Aug 7, 2025	$0.19est. $0.36	-47.22%miss	$654.8MSEC filing	+34.7%from $486.3M
Mar 31, 2025Reported May 8, 2025	$0.44est. $0.33	+33.33%beat	$620.4MSEC filing	+53.4%from $404.4M
Dec 31, 2024Reported Feb 27, 2025	$0.37est. $0.21	+71.82%beat	$2.03B · FYSEC filing	No year-ago quarter

Open: $34.05
High: $34.50
Low: $32.75
Prev close: $34.50
52-wk high: $51.60
52-wk low: $18.08
Mkt cap: $1.70B
P/E: 31.9x
ROE: +9.8%
Fwd P/E: 9.0x
Beta: 1.24
P/S: 0.4x
P/B: 2.0x
Profit margin: +1.4%
Op margin: +3.9%

Fundamentals

Is the business strong?

Reasonably priced and running thin margins.

Net margin: 1.4%
P/E: 31.94
Forward P/E: 9.01
Market cap: $1.7B

Valuation

P/S0.43
P/B2.00

Quality

Operating margin3.9%
ROE9.8%
ROA2.8%

Growth

Beta1.24

Technicals

Price structure

This stock is under pressure.

Trend

Under pressure

0 / 100

RSI 14

31balanced

20D volatility

59%annualized

52-week range

$33.77

$18.08$51.60

20D support

$31.46recent floor

20D resistance

$41.00recent ceiling

Returns

5D -8.4%20D -12.1%60D -17.3%

Price vs moving averages

SMA20 -9.1%SMA50 -8.5%SMA200 -1.1%

Volume pace

0.79xvs prior 20D

Astrana Health Inc

Smart money at a glance

What do analysts expect?

Questions about ASTH filings

Smart money on ASTH

Questions about ASTH filings

What funds are doing

How top traders are positioned

Unlock everything for $29/month

Earnings came in 19.0% below what analysts expected.

What the street expects next

Previous reports

Is the business strong?

Price structure

Ask it in Claude or ChatGPT.

Astrana Health Inc

Smart money at a glance

What do analysts expect?

Questions about ASTH filings

Smart money on ASTH

Questions about ASTH filings

What funds are doing

How top traders are positioned

Unlock everything for $29/month

Earnings came in 19.0% below what analysts expected.

What the street expects next

Previous reports

Is the business strong?

Price structure

Ask it in Claude or ChatGPT.

Astrana Health Inc

Overview

Questions about ASTH filings

Smart money

Unlock everything for $29/month

Earnings

Previous reports

Financials

Technicals

Ask it in Claude or ChatGPT.

Astrana Health Inc

Overview

Questions about ASTH filings

Smart money

Unlock everything for $29/month

Earnings

Previous reports

Financials

Technicals

Ask it in Claude or ChatGPT.